Catalyst Wire Dossier Catalyst Wire Dossier

Triplixam (amlodipine/indapamide/perindopril) fixed-dose combination

Amlodipine/Indapamide/Perindopril · Servier
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Triplixam (amlodipine/indapamide/perindopril) fixed-dose combination, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

See pricing